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Published studies have identified novel sense transcripts in latent human cytomegalovirus (HCMV) infection. These
cytomegalovirus latency-associated transcripts (CLTs) have start sites upstream from the MIE gene productive start site
(PSS). We evaluated the expression of the sense CLTs in an in vitro HCMV productive infection. Transcripts with initiation
sites upstream from the PSS were detected in infected human fibroblasts using reverse transcription–polymerase chain
reaction and 59 rapid amplification of cDNA ends (RACE) analysis. DNA sequencing of 59 RACE PCR products confirmed that
the start sites were consistent with sense CLT expression. Furthermore, ribonuclease protection assay analysis showed that
transcripts initiating at the latent start site-1 were most abundant at late times postinfection after transcription from the PSS
had decreased. In addition, transcription consistent with sense CLT expression was identified in HCMV-infected dTHP-1
cells, monocyte-derived macrophages, and endothelial cells, as well as in clinical isolate-infected human fibroblasts. These
findings clearly demonstrate the expression of sense CLTs during in vitro HCMV infection. © 2000 Academic PressKey Words: human cytomegalovirus; HCMV; latency transcripts; CLTs; reverse transcription–polymerase chain reaction;
rapid amplification of cDNA ends; ribonuclease protection.INTRODUCTION
Human cytomegalovirus (HCMV) has the ability to es-
tablish a latent infection that persists for the life of the
infected host. In individuals with immune system sup-
pression, the latent virus can reactivate and cause se-
vere disease. In fact, the majority of HCMV-related dis-
ease is due to reactivation of latent virus. Despite the
significant role that latency plays in HCMV pathogenesis,
little is known about the molecular mechanisms involved
in establishing and maintaining this stage of the viral life
cycle. The identification and characterization of latency-
associated transcripts form an important initial step to-
ward achieving a better understanding of the molecular
events involved in HCMV latency.
Novel sense and antisense transcripts have been
found to be expressed in experimentally infected granu-
locyte-macrophage progenitor cells, as well as in bone
marrow cells from naturally infected individuals (Kondo
et al., 1994, 1996; Kondo and Mocarski, 1995; Hahn et al.,
1998; Slobedman and Mocarski, 1999). These HCMV
latency-associated transcripts (CLTs) were mapped to
the major immediate-early (MIE) region of the viral ge-
nome. The sense CLTs were found to have start sites
(LSS-1 and LSS-2) in the MIE promoter-enhancer region
1 To whom reprint requests should be addressed at Department of
ediatrics, Division of Infectious Disease, Neurosciences Bldg., Room
00, 1515 Newton Ct., Davis, CA 95616. Fax: 530-754-5054. E-mail:
ataylorwiedeman@ucdavis.edu.
467356 and 292 bp upstream from the MIE productive start
site (PSS).
In this study, we investigated the possibility that the
sense CLTs are expressed during in vitro HCMV produc-
tive infection. A specific product was detected in HCMV-
infected human fibroblasts using a reverse transcription–
polymerase chain reaction (RT–PCR) method designed
to evaluate transcription occurring upstream from the
PSS. The RT–PCR product was detected over a wide
range of times postinfection in human fibroblasts and
was present in a number of different cell types and in
clinical isolate-infected human fibroblasts. Transcripts
with start sites consistent with that of the sense CLTs
were detected in HCMV-infected human fibroblasts us-
ing 59 rapid amplification of cDNA ends (59 RACE). Fur-
thermore, a ribonuclease protection assay (RPA) de-
signed to detect transcripts initiating from the LSS-1,
LSS-2, and PSS revealed that transcripts originating up-
stream from the PSS were most abundant at late times
postinfection after the levels of the major lytic transcripts
had reached a maximum. These findings support the
conclusion that the sense CLTs are expressed during in
vitro productive infection and are most abundant late in
infection.
RESULTS
RT–PCR analysisAn RT–PCR method was developed to evaluate
whether transcription originating upstream from the MIE
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468 LUNETTA AND WIEDEMANgene PSS was occurring in in vitro HCMV productive
infection. First-strand cDNA was synthesized using an
exon 2 primer and amplified by PCR using a nested exon
2 primer and an LSS-1-specific primer (Fig. 1). A 512-bp
RT–PCR product was detected when RNA harvested
from Toledo-infected primary human embryonic lung fi-
broblasts (HFs) at 5 days postinfection (d.p.i.) was re-
verse-transcribed using this method (Fig. 2A, lane 2).
Southern blot analysis using probe LSS153 verified that
the product was a specific amplification product. RNA
was isolated from uninfected HFs in parallel with the
other samples to control for cross-contamination (Fig.
2A, lane 1). Expected results were obtained for all of the
controls (Fig. 2A, lanes 3–5).
To determine whether the transcription initiating up-
stream of the PSS was temporally regulated, RNA was
isolated from Toledo-infected HFs at 2, 6, 18, and 48 h
postinfection (h.p.i.) and 5 and 7 d.p.i. and analyzed by
LSS-1-specific RT–PCR. A 512-bp product was detected
at all of the time points evaluated (Fig. 2B, lanes 2–7).
Southern blot analysis using probe LSS153 verified that
the products were specific amplicons. Again, expected
results were obtained for the uninfected sample and the
controls (Fig. 2B, lanes 1 and 8–10).
RT–PCR analysis of various cell types infected with
FIG. 1. Locations and nucleotide sequences of the primers and prob
the MIE gene region are shown. The various start sites are indicatedHCMV was performed to determine whether transcrip-
tion occurring upstream of the MIE gene PSS was re-stricted to HFs. Several different cell types were chosen
that have been shown to be either latently or persistently
infected by HCMV during natural infection. RNA was
isolated from Toledo-infected differentiated THP-1 cells
and monocyte-derived macrophages (MDMs) at 7 d.p.i.
RNA was isolated from AD169-infected aortic endothelial
cells at 24 h.p.i. A 512-bp RT–PCR product was observed
for each of the cell types examined (Fig. 2C, lanes 2–5).
Southern blot analysis with probe LSS153 verified that
the amplification products were specific.
The expression of transcripts initiating upstream of the
MIE gene PSS was also evaluated in HFs infected with
clinical isolates of HCMV using the LSS-1-specific RT–
PCR method. RNA was isolated from clinical isolate-
infected HFs at 7 d.p.i. A 512-bp RT–PCR product was
obtained for each of the isolates examined (Fig. 2C,
lanes 6 and 7). Southern blot analysis with probe LSS153
verified that the amplification products were specific.
59 RACE analysis
To map the 59 ends of the transcript(s) detected by
RT–PCR, 59 RACE methodology was used. Initial experi-
ments were performed using cDNA synthesized with
RNA from Toledo-infected HFs at 5 d.p.i. and random
d for RT–PCR, 59 RACE, and RPA procedures. The first three exons of
, LSS-1, and LSS-2.hexanucleotide primers. The cDNA was purified and
tailed with cytosine. The tailed cDNA was amplified with
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469SENSE CLT EXPRESSION IN IN VITRO PRODUCTIVE INFECTIONan abridged anchor primer and an exon 2 primer (Fig. 1
and diagram in Fig. 3A). Ethidium bromide-stained aga-
rose gels and corresponding Southern blots of the 59
ACE PCR products obtained from this amplification are
hown in Fig. 3A. The anchored PCR products were
oaded as replicate samples in lanes 1–3 of the two gels,
nd the membranes were hybridized with a probe spe-
ific for CMV sequence either downstream (4153) or
pstream (LSS153) of the MIE gene PSS. Probe LSS153
as designed to detect transcripts originating upstream
rom the PSS, whereas 4153 was specific for transcripts
FIG. 2. RT–PCR analysis of transcription originating upstream from th
Southern blots of products generated from RT–PCR analysis of Toledo-
and various HCMV-infected cell types and clinical isolate-infected HFs
control: H2O; 4, PCR positive control: 10
2 copies Toledo DNA; 5, PCR n
6, 18, and 48 h.p.i. and 5 and 7 d.p.i., respectively; 8, RT reaction neg
negative control: H2O. (C) Lane 1, uninfected HFs; 2, AD169-infected AE
oledo-infected HFs; 6, adult clinical isolate-infected HFs; 7, fetal clinic
control: 102 copies Toledo DNA; 10, PCR negative control: H2O; M, 1 k
he size of the adjacent DNA markers. The arrows to the right of the initiating at all three start sites (PSS, LSS-1, and LSS-2).
n intense band migrating just below the 220-bp markerwas observed in the infected fibroblast sample (Fig. 3A,
lane 1 of both gels) and corresponds to amplification of
transcripts originating from the PSS (194 bp). A number
of other amplification product bands were also visible in
lane 1 of the gels migrating above the 220-bp marker.
Southern blot analysis with probe 4153 yielded multiple
probe positive products (Fig. 3A, lane 1), a very promi-
nent band corresponding to the major lytic transcripts,
and at least two other higher-molecular-weight bands.
However, when the same PCR products were probed
with LSS153, only the higher-molecular-weight species
gene PSS. Ethidium bromide-stained agarose gels and corresponding
d HFs (A), Toledo-infected HFs at various time points postinfection (B),
Lane 1, uninfected HFs; 2, Toledo-infected HFs; 3, RT reaction negative
control: H2O. (B) Lane 1, uninfected HFs; 2–7, Toledo-infected HFs 2,
ontrol: H2O; 9, PCR positive control: 10
2 copies Toledo DNA; 10, PCR
oledo-infected differentiated THP-1 cells; 4, Toledo-infected MDMs; 5,
te-infected HFs; 8, RT reaction negative control: H2O; 9, PCR positive
DNA ladder (Gibco BRL). The numbers to the left of the gels indicate
indicate the position of the specific 512-bp RT–PCR product.e MIE
infecte
(C). (A)
egative
ative c
C; 3, T
al isolawere visible, confirming that the products represented
transcripts originating upstream from the PSS. One of the
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470 LUNETTA AND WIEDEMANprobe-positive products exhibited a migration consistent
with transcripts initiating at LSS-1 (548 bp). Although a
product band was visible in both gels of the expected
size (486 bp) for LSS-2 transcripts, a distinct correspond-
ing band was not evident in the Southern blots. At least
two additional specific amplification products (indicated
by asterisks) were generated from this 59 RACE PCR. The
structure of these products remains to be determined.
However, the size of the products (;260 and ;400 bp),
as well as the fact that the products were consistently
detected by 59 RACE, suggests that additional MIE gene
ranscription start sites are present downstream from
SS-2 (between LSS-2 and PSS). No amplification prod-
cts were observed in the infected sample in the ab-
ence of terminal deoxynucleotidyl transferase (TdT)
Fig. 3A, lane 2), indicating specific amplification of cy-
FIG. 3. 59 RACE PCR analysis of Toledo-infected HFs. Ethidium brom
PCR products. RNA was isolated from Toledo-infected HFs at 5 d.p.i. a
1 mg of RNA and random hexamers (A) or an exon 2 gene-specific pr
purified. An aliquot of the cDNA was tailed with dCTP and rTdT (1). As
was also incubated with dCTP in the absence of TdT (2). The cDNA w
DIG-labeled DNA molecular weight marker VI (lane M) was used for esti
generated from transcripts initiating at PSS and LSS-1 are indicated to
products. These products were not cloned in this study, but the produ
(between LSS-2 and the PSS). The numbers to the left of the images in
shows the positions of the PCR primers and the probes used for each e
start sites. (A) The 59 RACE PCR results obtained using a gene-specific p
loaded in lanes 1–3, and the blots were hybridized with probe 4153 or
TdT; negative control: H2O plus TdT. (B) The 59 RACE PCR results obtain
Lane 1, Toledo-infected HFs plus TdT; 2, Toledo-infected HFs minus Tdosine-tailed cDNA in the sample containing TdT, or in
he negative control (Fig. 3A, lane 3). This 59 RACEexperiment verified that transcription originating up-
stream of the MIE gene PSS was occurring in Toledo-
infected HFs. It was also evident from this experiment
that in productive infection, transcripts initiating up-
stream of the PSS were present in relatively low abun-
dance compared with the major lytic transcripts. To map
the 59 ends of the transcripts initiating upstream of the
PSS, another 59 RACE experiment was performed and
the products TA cloned (Fig. 3B). In this experiment, a
gene-specific PCR primer located upstream of the PSS
was used for PCR to avoid amplification of transcripts
initiating from the PSS and therefore allow for selective
cloning of PCR products representing only transcripts
originating upstream of the PSS. The 59 RACE PCR prod-
ucts were separated on an ethidium bromide-stained
agarose gel and subjected to Southern blot analysis with
ained agarose gels and the corresponding Southern blots of 59 RACE
m uninfected HFs. First-strand cDNA synthesis was carried out using
). The RNA template was degraded using RNase, and the cDNA was
ol for nonspecific amplification in the 59 RACE PCR, an aliquot of cDNA
plified using a gene-specific primer and an abridged anchor primer. A
the size of product bands. The positions of the anchored PCR products
ht of the images. The asterisks indicate additional probe-positive PCR
suggest additional MIE gene start sites downstream from the LSS-2
the size in bp of the adjacent DNA marker. The diagram in each panel
ent as well as the expected sizes for transcripts initiating at the various
ownstream from the MIE productive start site. Replicate samples were
. Lane 1, Toledo-infected HFs plus TdT; 2, Toledo-infected HFs minus
ng a gene-specific primer upstream from the MIE productive start site.
ninfected HFs plus TdT; 4, negative control: H2O plus TdT.ide-st
nd fro
imer (B
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as am
mating
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ct sizes
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xperim
rimer d
LSS153probe LSS153. A discrete product band migrating just
above the 298-bp marker was visible in the gel for the
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471SENSE CLT EXPRESSION IN IN VITRO PRODUCTIVE INFECTIONToledo-infected HF sample (Fig. 3B, lane 1) and was
consistent with transcripts initiating at LSS-1 (317 bp).
Southern blot analysis with probe LSS153 demonstrated
that the PCR product was specific. Although an amplifi-
cation product corresponding to LSS-2 transcripts (255
bp) was not clearly visible in the gel or the blot, sequence
data obtained from PCR product cloning did confirm
transcription initiating at LSS-2 (see later). Another broad
probe-positive band was visible on the Southern blot
with a migration between 154 and 220 bp. This band
represents amplification products that would correspond
to the 400-bp probe-positive species detected in the 59
ACE experiment using the PCR primer downstream
rom the PSS (Fig. 3A). No amplification products were
bserved in the absence of TdT (Fig. 3B, lane 2), indicat-
ng specific amplification of cytosine-tailed cDNA in the
nfected samples containing TdT. No product was ob-
erved in the sample containing RNA from uninfected
Fs (Fig. 3B, lane 3) or the sample containing water in
he place of RNA (Fig. 3B, lane 4).
A cloning of 59 RACE PCR products
The PCR products obtained from the 59 RACE experi-
ent using a gene-specific primer located upstream of
he PSS were TA cloned, and the nucleotide sequences
ere determined. Ten clones were subjected to restric-
ion enzyme digestion to determine the insert size. Of the
0 clones screened, 7 had inserts with sizes consistent
ith transcripts initiating at LSS-1, whereas 1 was con-
istent with transcripts initiating from LSS-2. Of the re-
aining 2 inserts, 1 was larger than the “LSS-1 clones”
T
DNA Sequences
Insert sizea DNA Sequence
LSS-1 2
59. . .AGTACATCAAGTGTATCATATGCCA
LSS-1 59. . . GGGGCAT--GCCA
LSS-1 59. . . GGGGATCATATGCCA
LSS-1 59. . . GGGGATCAAGTGTATCATATGCCA
LSS-1 59. . . GGGGTTCAAGTGTATCATATGCCA
LSS-1 59. . .GGGGCATCAAGTGTATCATATGCCA
LSS-2 2
59. . .CCGCCTGGCATTATGCCCAGTACAT
LSS-2 59. . . GGGGATGCCCAGTACAT
Other 59. . .GGGGAATGACGGTAAATGGCCCGCC
Other 59. . .GGGGTGCCAATAGGGACTTTCCATT
a Clones have been grouped according to their insert size (“LSS-1 o
b DNA sequence of the HCMV AD169 MIE gene region from 2366 t
c DNA sequence of the HCMV AD169 MIE gene region from 2304 tnd the other was intermediate in size to the “LSS-1 and
2 clones.” The 10 cDNA clones were DNA sequenced,and the data obtained are summarized in Table 1. The
DNA sequence data obtained from the 7 “LSS-1-sized”
cDNA clones exhibited heterogeneity, and therefore a
single start site could not be defined for transcripts
originating from the LSS-1 region of the genome in pro-
ductive infection. However, all 7 of the “LSS-1-sized”
cDNA clones had 59 ends that mapped proximate to the
LSS-1, with the majority mapping slightly upstream (7–8
bp) of the LSS-1. This would place the transcription start
site at 2361, exactly 25 bp downstream from a putative
TATA box. The cDNA sequenced from the “LSS-2-sized”
clone had a 59 end that mapped to the LSS-2 (2292). The
two other clones exhibited 59 ends that mapped to 320
and 430 bp upstream of the PSS. A cDNA clone that
would correspond to the 59 RACE PCR products indica-
tive of transcripts initiating downstream from LSS-2 (be-
low 292 bp) were not detected within the group of clones
screened. The fact that only 10 white colonies were
screened may account for the lack of detection, espe-
cially because the PCR products generated were small
and the resulting inserts may not have interrupted the
reading frame of the lacZ gene. RPA analysis of Toledo-
infected HFs did yield a minor protected fragment after
long exposure that would correspond to transcripts ini-
tiating downstream from LSS-2 (data not shown). The
results obtained from the TA cloning of the 59 RACE PCR
products confirm that transcripts initiating proximate to
the MIE gene LSS-1 and at the LSS-2 are expressed in
Toledo-infected HFs.
RPA analysis
ACE PCR Clones
Start Site No. of clones
GCCCC. . .39b 2354
GCCCC. . .39 2350 n 5 2
GCCCC. . .39 2352 n 5 1
GCCCC. . .39 2361 n 5 1
GCCCC. . .39 2361 n 5 2
GCCCC. . .39 2362 n 5 1
TATGG. . .39c 2292
TATGG. . .39 2292 n 5 1
TTATG. . .39 2320 n 5 1
CAATG. . .39 2430 n 5 1
-sized” or other).
. LSS-1 identified by Kondo and others (1995, 1996) is shown.
. LSS-2 identified by Kondo and others (1995, 1996) is shown.ABLE 1
of 59 R
AGTAC
AGTAC
AGTAC
AGTAC
AGTAC
AGTAC
GACCT
GACCT
TGGCA
GACGT
r LSS-2RPA analyses were performed to confirm the 59 RACE
results and to evaluate the relative abundance of the
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472 LUNETTA AND WIEDEMANvarious MIE region transcripts. A digoxigenin (DIG) or
radiolabeled RNA probe was designed to detect tran-
scripts initiating at LSS-1, LSS-2, and the PSS (Fig. 1). The
expected sizes of the protected fragments were 475
nucleotides (nt) for LSS-1 transcripts, 413 nt for LSS-2,
and 120 nt for PSS. RNA from Toledo-infected fibroblasts
was incubated overnight with probe and then treated
with RNase. To confirm the 59 RACE mapping, an RPA
was conducted using RNA harvested from Toledo-in-
fected HFs at 5 d.p.i. (Fig. 4A). An uninfected HF RNA
sample and a sample containing only RNA probe were
run in parallel. A mock-digested (no RNase) probe-only
sample (no Toledo-infected RNA or uninfected HF RNA)
was also included. The absence of any signal in the
probe-only sample (plus RNase) or the uninfected HF
RNA sample indicated that unhybridized probe was com-
pletely digested and that the probe did not undergo any
self-protection or hybridize nonspecifically to uninfected
HF RNA. Two intense signals were observed in the
infected HF sample positioned between the 400- and
750-nt markers. The product migrating between the 400
and 500 nt was of the expected size for a protected
fragment generated from an LSS-1 transcript. The migra-
tion of the larger fragment positioned between 500 and
750 nt was of the expected size of a protected fragment
generated by the complete protection of the HCMV se-
quence of the probe (degradation by RNase of the vec-
tor-transcribed sequence surrounding the HCMV se-
FIG. 4. RPA analysis of Toledo-infected HFs. RNA from Toledo-infecte
to detect transcripts initiating from the MIE region LSS-1, LSS-2, and P
in loading buffer. The protected fragments were separated by electroph
fragments generated from a nonradioactive RPA analysis using infected
fragments generated from a radioactive RPA analysis using infected H
and 2, probe only (no RNase); 3, probe plus RNase; 4, uninfected HF R
Nase); 2, probe plus RNase; 3, uninfected HF RNA (50 mg); 4–6, infec
HF RNA at 12 (12 mg), 24 (11 mg), and 72 (20 mg) h.p.i., respectively; M,
ositions of the protected fragments generated from transcripts origin
f the image indicate the size in nucleotides of the adjacent RNA marquence of the riboprobe). This result indicates transcrip-
tion occurring upstream from the LSS-1. This species
a
sappears too large to be a protected fragment resulting
from the one 59 RACE product that had a 59 end located
pstream from LSS-1; a protected fragment from this
ranscript would be 551 nt. This protected fragment may
epresent large read-through transcripts, typical of tran-
cription occurring at late times after infection, that were
ot efficiently amplified under the conditions used for the
9 RACE PCR. Although not apparent in this RPA, a faint
and was also observed above the 100-nt marker in
ther RPA experiments using infected RNA harvested at
his time point. This protected species represented tran-
cripts initiating at the PSS (120 nt). Transcripts originat-
ng from the LSS-2 were not detected by this RPA, indi-
ating a very rare abundance. A second RPA was per-
ormed to evaluate the expression of the MIE region
ranscripts over a range of times postinfection (Fig. 4B).
NA was harvested from Toledo-infected HFs at 2, 12,
4, 48, and 72 h.p.i. and 7 d.p.i. It should be noted that 50
mg of RNA was not available for the 12-, 24-, and 72-h.p.i.
samples. The three infected HF samples containing 50
mg of RNA were applied to the gel in adjacent lanes
separate from the other samples to allow for direct com-
parison. Expected results were obtained for all of the
controls. A band corresponding to transcripts originating
from the PSS was visible at all of the time points ana-
lyzed. As expected, the PSS transcripts were present as
early as 2 h.p.i. and maximum expression levels were
observed at 12 h.p.i., even though only 12 mg of RNA was
or uninfected HFs was incubated with a labeled RNA probe designed
er digestion with RNase, the RNA was precipitated and resuspended
through a denaturing polyacrylamide gel. (A) Northern blot of protected
A at 5 d.p.i. and a DIG-labeled probe. (B) An autoradiogram of protected
at a range of times postinfection and a 32P-labeled probe. (A) Lanes 1
mg); 5, infected HF RNA (50 mg) at 5 d.p.i. (B) Lane 1, probe only (no
RNA (50 mg) at 2 and 48 h.p.i. and 7 d.p.i., respectively; 7–9, infected
entury Marker Plus molecular weight marker. The arrows indicate the
t the LSS-1 (475 nt) and PSS (120 nt). The numbers to the left or rightd HFs
SS. Aft
oresis
HF RN
F RNA
NA (50
ted HF
RNA Cssayed for this time point. A protected fragment corre-
ponding to the LSS-1 latency transcripts was not appar-
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473SENSE CLT EXPRESSION IN IN VITRO PRODUCTIVE INFECTIONent until 7 d.p.i. Only 20 mg of RNA was assayed at
72 h.p.i. and could explain the lack of detection of the
transcripts at this time point. Regardless, it was clear
from both RPA analyses that the LSS-1 latency tran-
scripts were most abundant late in infection (5 and
7 d.p.i.), after the levels of the major lytic transcripts had
diminished. RPA analysis was also used to evaluate
whether the LSS-1 latency transcripts were expressed in
clinical isolate-infected HFs. An RPA was performed us-
ing RNA (25 mg) isolated from fetal clinical isolate-in-
ected HFs at 7 d.p.i. A pattern of protected fragments
dentical to that observed with Toledo-infected HFs was
enerated when RNA from fetal clinical isolate-infected
Fs at 7 d.p.i. was analyzed (data not shown). This
inding demonstrated that expression of transcripts initi-
ting at the LSS-1 of the MIE gene was not limited to
CMV strains that have been subjected to laboratory
assage.
DISCUSSION
A specific product was generated using RNA har-
ested from Toledo-infected HFs and an RT–PCR method
esigned to detect transcription initiating upstream from
he MIE gene PSS. Additional RT–PCR analysis of in-
ected HFs detected transcription initiating upstream
rom the PSS as early as 2 h.p.i. and as late as 7 d.p.i. In
ddition, a specific RT–PCR product was obtained from
linical isolate-infected HFs, indicating that the expres-
ion was not an adaptation induced by the laboratory
assage of the virus. It was also determined that this
xpression was not limited to fibroblasts. Transcription
as detected in three additional cell types after infection
ith HCMV. An RT–PCR signal was detected in a differ-
ntiated monocytic cell line infected with Toledo at
d.p.i. and in primary MDMs. Monocytes/macrophages
re myeloid lineage cells that have been shown to be
nvolved in latent viral carriage in healthy HCMV-sero-
ositive individuals (Taylor-Wiedeman et al., 1991; Sin-
clair and Sissons, 1996; Bolovan-Fritts et al., 1999). RT–
PCR signal was also detected in AD169-infected aortic
endothelial cells 24 h after infection. Endothelial cells
have been persistently infected with HCMV in vitro and
may play a role in HCMV pathogenesis (Fish et al., 1998;
Vossen et al., 1996). Therefore, by RT–PCR analysis it
was determined that transcription upstream of the PSS
was active in a variety of cell types infected with HCMV.
Of course, a more detailed analysis would be necessary
to identify different patterns of MIE region transcript
expression among these cell types.
To confirm that the transcript detected by RT–PCR
originated from the LSS-1, 59 RACE methodology was
used. Using a primer upstream from the PSS in 59 RACE
PCR, products of the approximate size for transcripts
initiating at LSS-1 and LSS-2 were generated. DNA se-
quencing of the 59 RACE PCR products revealed startsites similar to LSS-1 and identical to LSS-2. The 39 ends
of these transcripts have not been mapped in productive
infection, so it is not known whether they share the same
splicing patterns as that seen in latent infection.
An evaluation of the relative abundance of the MIE
region transcripts initiating at LSS-1, LSS-2, and the PSS
in HCMV-infected HFs was performed using RPA analy-
sis. Protected fragments corresponding to transcripts
originating at the PSS were detected at all time points
postinfection and, as expected, were most abundant at
immediate-early times postinfection. In contrast, the
LSS-1 latency transcripts were most abundant at late
times postinfection, after the level of the PSS transcripts
had decreased. It is not known whether the levels of the
LSS-1 latency transcripts at 5 and 7 d.p.i. represent an
accumulation of the transcripts, because transcription
upstream from the PSS was detected by RT–PCR as early
as 2 h.p.i., or are due to an increase in transcription
initiating at the latency start site. The low abundance of
the LSS-1 latency transcripts in HFs at immediate-early
times after HCMV infection may account for the inability
of others to detect the transcripts by RPA analysis, be-
cause the assay was performed using RNA harvested
from infected HFs at 2 h.p.i. (Kondo et al., 1996). The
same laboratory has since detected the latency tran-
scripts in productively infected HFs as early as 8 h.p.i.
using RPA analysis (White et al., 2000). It is clear that
transcripts initiating from LSS-1 are more abundant than
LSS-2 in productive infection, because transcripts corre-
sponding to LSS-1 use were easily detectable by 59
RACE and RPA procedures, whereas LSS-2 transcripts
were detected only after cloning of 59 RACE PCR prod-
ucts. This finding is consistent with that found in the
experimental system of latency where transcripts corre-
sponding to LSS-1 use were predominant over those
corresponding to LSS-2 use (Kondo et al., 1996).
The function of the latency-associated sense tran-
scripts in productive or latent infection remains to be
determined. A number of open reading frames can be
predicted from their sequence. The largest predicted
open reading frame encoded by LSS-1 or LSS-2 tran-
scripts is ORF 94. Using an ORF 94 knockout virus
(RC2710), it was recently shown that ORF 94 is not
required for productive or latent infection in culture
(White et al., 2000).
The fact that the sense CLTs are present during both
latent and productive infection is consistent with that
observed for LAT expression during other herpesvirus
infections. For example, in herpes simplex virus type 1,
the major 2.0-kb LAT is expressed in ganglia during
acute infection in mice, although to a lesser extent than
that observed during latent infection (Spivack and Fraser,
1987). In addition, the Epstein–Barr virus LAT, EBNA-1, is
expressed during the lytic cycle, although it is under the
control of a promoter distinct from those used during
latency (Lear et al., 1992; Schaefer et al., 1995; Nonkwelo
n
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474 LUNETTA AND WIEDEMANet al., 1996). Transcription occurs from the porcine her-
pesvirus 1, or pseudorabies virus, LAT gene during pro-
ductive infection, although the RNAs were found to be
distinct from the large latency transcript (Cheung, 1990;
Jin and Scherba, 1999).
In conclusion, sense transcripts with start sites in the
promoter-enhancer region of the MIE gene were identi-
fied during in vitro HCMV productive infection. The initi-
ation sites of these sense transcripts mapped to the
latent start sites previously described for the sense
CLTs. The LSS-1 transcripts were predominant over
LSS-2 transcripts and were found to be most abundant at
late times after infection. Additionally, RT–PCR analysis
demonstrated that transcripts with start sites upstream
from the PSS were expressed in HCMV-infected HFs
over a wide range of times postinfection and were also
present in a variety of different cell types.
Further studies designed to evaluate the role of the
sense CLTs in in vitro HCMV productive infection are
warranted, especially considering the inherent difficul-
ties associated with the study of HCMV latency. Defining
the role of the transcripts in productive infection may
provide insight into their function during latent infection.
MATERIALS AND METHODS
Cell culture
Primary human embryonic lung fibroblasts (HFs) were
cultured in Iscove’s modified Eagle’s medium (IMDM)
containing 5–10% (v/v) fetal calf serum (FCS). Primary
MDMs were prepared by adhering peripheral blood
mononuclear cells obtained from seronegative individu-
als to plastic tissue culture dishes for 15 min in phos-
phate-buffered saline. Nonadherent cells were removed,
and the remaining adherent cells were cultured for 6 d in
IMDM containing 10% (v/v) FCS plus hydrocortisone (50
mM). The cells were incubated overnight with phorbol-
12-myristate-13-acetate (PMA; 20 nM) the day before
viral infection. Transformed human premonocytic (THP-1)
cells (American Type Culture Collection, Rockville, MD)
were differentiated with hydrocortisone and PMA as de-
scribed here for MDMs. Aortic endothelial cells were
cultured as described in the manual provided by the
supplier (Clonetics Corporation, San Diego, CA).
Viruses
HCMV Toledo and AD169 strains were provided by Dr.
E. S. Mocarski (Stanford University). HCMV AD169 was
originally obtained from American Type Culture Collec-
tion, in 1986 (passage .200). HCMV Toledo was origi-
ally acquired from Dr. Stanley Plotkin and was passage
when received from Dr. Mocarski. The Toledo and
D169 viral strains were propagated and plaque-titered
n HFs. All HFs and viral stocks were negative for myco-
lasma, acholeplasma, and ureaplasma using a Myco-
9
2plasma PCR Elisa kit (Roche Molecular Biochemicals,
Welwyn Garden City, UK). The HCMV clinical isolates
were derived from infected tissue obtained from a bron-
choaveolar lavage of an adult male (adult clinical isolate)
and lung from an abortus (fetal clinical isolate). HFs were
infected with Toledo and the clinical isolates at a multi-
plicity of infection (m.o.i.) of 1. Differentiated THP-1 cells
and MDMs were infected with Toledo at an m.o.i. of 1
and 2, respectively. Cultured aortic endothelial cells were
infected with AD169 at an m.o.i. of 1.
RNA isolation
Total cellular RNA was isolated using an RNA extrac-
tion kit (RNAgents; Promega, Madison, WI) based on the
method described by Chromczynski and Sacchi (1987).
Contaminating genomic DNA was removed from RNA
preparations by incubation with RQ1 RNase-free DNase
(Promega) as described in the RNAgents kit technical
bulletin. The RNA integrity and concentration of the sam-
ples were estimated by running a small aliquot on a 1%
denaturing agarose gel. Known amounts of bacterial
rRNA served as quantification standards. The RNA con-
tent of the samples was also determined spectrophoto-
metrically.
RT–PCR
First-strand cDNA synthesis was carried out using
random hexanucleotide primers (Promega) or an exon 2
gene-specific primer and SuperScript II reverse tran-
scriptase (GIBCO BRL, Grand Island, NY). An initial an-
nealing reaction (25 ml) was performed with template
RNA (10 ng for RT–PCR shown in Figs. 2A and 2B and 100
ng for Fig. 2C), primer [random hexanucleotide (500 ng)
or gene-specific (5 pmol)]. and rRNasin (10 U). The sam-
ples were incubated for 10 min at 68°C, followed by 45 s
at 65, 60, 55, 50, 45, 40, 35, 30, and 25°C, and finally 10
min at 25°C. A reaction mix (25 ml) was then added to the
samples to yield a 50-ml reaction volume containing 50
mM Tris–HCl (pH 8.3), 75 mM KCl, 3 mM MgCl2, 10 mM
ithiothreitol (GIBCO BRL), 500 mM concentration of
each deoxynucleotide triphosphate (dNTP; Roche Mo-
lecular Biochemicals), and 200 U of SuperScript II re-
verse transcriptase (GIBCO BRL). The samples were
then incubated at 42°C for 1 h, followed by 8 min at 95°C.
The samples were cooled to 4°C and used immediately
for cDNA amplification or stored at 270°C. cDNA (5 ml)
as amplified in a 50-ml reaction mix containing 10 mM
ris–HCl, pH 8.5 at 25°C, 50 mM KCl, 1.5 mM MgCl2,
.01% gelatin, 0.5% Tween 20, 0.1% Triton X-100, 1 mM
oncentration of each primer (GIBCO BRL), 200 mM con-
entration of each dNTP, and 1 U Taq DNA polymerase
Promega). A modified hot-start and an initial step-down
nnealing reaction were used. An initial denaturation at
4°C for 4 min, was followed by 10 cycles of 94°C for
0 s, 67–58°C (step-down 1°C each cycle) for 20 s, and
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475SENSE CLT EXPRESSION IN IN VITRO PRODUCTIVE INFECTION72°C for 1 min. Fifty cycles of the following were then
performed: 94°C for 20 s, 55°C for 20 s, and 72°C for 1
min, followed by a final 7 min at 72°C. PCR products (5
ml) were separated by electrophoresis through a 1.5%
agarose gel, and the bands were visualized by staining
with ethidium bromide. All reactions were carried out in
a GeneAmp PCR System 2400 thermal cycler Applied
Biosystem (Foster City, CA). Positive and negative con-
trols were included with each set of samples analyzed by
RT–PCR. For the RT reaction and PCR negative controls,
water was substituted for DNA template. Purified Toledo
DNA (100 copies) served as DNA template for the PCR
positive control. According to the known sequence of
AD169, the expected size of the spliced product gener-
ated from this RT–PCR is 512 bp, whereas the DNA PCR
product size is 1339 bp. The locations and nucleotide
sequences of the primers and the probe used for RT–
PCR are shown in Fig. 1.
RACE
A 59 RACE kit (GIBCO BRL) was used to map the 59
ends of the transcripts initiating upstream from the PSS.
RNA was isolated from Toledo-infected HFs at 5 d.p.i.
First-strand cDNA synthesis was carried out using 1 mg
RNA and random hexanucleotide primers or an exon 2
gene-specific primer as described earlier. cDNA was
purified and dC-tailed as described in the manual sup-
plied with the kit. Tailed cDNA (5 ml) was amplified in a
50-ml reaction mix containing 10 mM Tris–HCl (pH 8.5 at
5°C), 50 mM KCl, 1.5 mM MgCl2, 0.01% gelatin, 0.5%
Tween 20, 0.1% Triton X-100, 500 nM concentration of
each primer (GIBCO BRL), 200 mM of concentration of
ach dNTP, and 1 U Taq DNA polymerase (Promega). A
odified hot start was performed, followed by an initial
enaturation at 94°C for 4 min. Thirty-five cycles of the
ollowing were then performed: 94°C for 45 s, 55°C for
5 s, and 72°C for 1 min, followed by a final 7 min at
2°C. PCR products (25 ml) were separated by electro-
horesis through an agarose gel (1.5%), and the bands
ere visualized by staining with ethidium bromide. The
ocations and nucleotide sequences of the primers and
robes used for 59 RACE are shown in Fig. 1. The ex-
ected sizes (CMV sequence plus 36-bp anchor primer)
or transcripts initiating at the various MIE start sites
ere as follows for 59 RACE PCR with primer down-
tream from PSS: 548, 486, and 194 bp for LSS-1, LSS-2,
nd PSS, respectively. For 59 RACE PCR with a primer
pstream of the PSS, the expected sizes of LSS-1 and
SS-2 transcripts were 317 and 255 bp, respectively.
A cloning of 59 RACE PCR products
RACE PCR products were TA cloned using an Original
A Cloning kit (Invitrogen Carlsbad, CA). An aliquot (2 ml)of the PCR sample was used in the ligation reaction.
InvaF9 cells were transformed as described in the man-
7
val provided by Invitrogen. White colonies (10) were
icked and cultured overnight in 2 ml Luria-Bertani me-
ium containing ampicillin (100 mg/ml). Plasmid DNA
isolation was performed using a Quantum Prep Plasmid
Mini Prep kit (BioRad, Hercules, CA). Plasmid DNA was
quantified by electrophoresis through an agarose gel
(0.8%) in the presence of DNA quantification standards
(GIBCO BRL). To determine the size of the cloned insert,
restriction enzyme digests of the plasmid DNA were
performed using EcoRI. The DNA was sequenced at the
UCD Division of Biological Sciences DNA Sequencing
Lab.
Southern blot analysis
The specificity of PCR amplification products was eval-
uated by Southern blot analysis using the following
methods. Agarose gels were blotted onto ZetaProbe
membranes (BioRad) using an alkaline transfer method.
Gels were transferred overnight in a 0.4 N NaOH solu-
tion. The membranes were rinsed briefly with 23 SSC
and then air-dried. When a DIG-labeled molecular weight
marker (VI; Roche Molecular Biochemicals) was used for
estimating the size of RACE PCR product bands, a tradi-
tional Southern blot transfer was performed. Hybridiza-
tion was carried out using the 53 SSC procedure de-
scribed in a DIG 39 end-labeling kit (Roche Molecular
Biochemicals) with the following exceptions. The mem-
brane was incubated in prehybridization solution for 1 h
at 37°C and then incubated overnight in hybridization
solution containing ;25 pmol of a DIG-labeled oligonu-
cleotide probe (4153 or LSS153; see Fig.1). The hybrid-
ized DIG probe was localized using an anti-DIG alkaline
phosphatase/CDP-Star chemiluminescent detection sys-
tem (Roche Molecular Biochemicals). End (39)-labeled
DIG-labeled probes were prepared with 100 pmol of
oligonucleotide (GIBCO BRL) and terminal deoxynucleo-
tidyl transferase (24 U, FPLC-pure; Amersham Pharmacia
Biotech, Picataway, NJ) using a DIG oligonucleotide 39
end-labeling kit (Roche Molecular Biochemicals).
Preparation of a labeled antisense RNA probe
A 592-bp PCR product was first generated using a
primer set that spanned a region 115 bp upstream from
the LSS-1 to 120 bp downstream from the PSS (see Fig.
1). Viral DNA prepared from Toledo-infected HFs was
used as template. The PCR product (2 ml) was TA cloned
s described earlier except that TOP10F9 cells (Invitro-
en) were used. The plasmid DNA was linearized with
indIII. An in vitro transcription reaction was performed
sing a Riboprobe kit (Promega) and [a-32P]CTP (NEN
ife Science Products, Boston, MA) or DIG-11-UTP
Roche Molecular Biochemicals). The size of the anti-
ense riboprobe generated from this transcription was
20 nt (592 nt of HCMV-specific sequence and 127 nt of
ector sequence). A labeled RNA molecular weight
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an RNA Century Marker Plus Template Set (Ambion,
Austin, TX).
RPA
The relative abundance of the MIE region transcripts
was evaluated using a Ribonuclease Protection kit
(Roche Molecular Biochemicals) with the following minor
modifications. RNA (50 mg, unless otherwise indicated)
harvested from Toledo-infected HFs or uninfected HFs,
and a radiolabeled (3 3 105 cpm) or DIG-labeled (35 ng)
NA probes were coprecipitated with sodium acetate
nd absolute ethanol. The RNA was resuspended in
ybridization buffer and incubated at 95°C for 5 min,
ollowed by an overnight incubation at 50°C. RNase
igestion was performed at 30°C for 45 min. When a
IG-labeled probe was used, RNase A was excluded
rom the digestion reaction. The RPA products were sep-
rated by electrophoresis through a denaturing poly-
crylamide gel (4.0% acrylamide/7 M urea). For the non-
adioactive RPA, the hybridized DIG-labeled RNA probe
as localized using an anti-DIG alkaline phosphatase/
DP-Star chemiluminescent detection system (Roche
olecular Biochemicals). For the radioactive RPA, a stan-
ard phosphor screen was exposed to the polyacryl-
mide gel, and the screen was scanned using a Storm
60 PhosphorImager (Molecular Dynamics, Sunnyvale,
A). The digitized image was analyzed using Image-
uant software (Molecular Dynamics). A labeled RNA
olecular weight marker (RNA Century Marker Plus;
mbion) was used to estimate the sizes of the protected
ragments.
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